SE8602931D0 - A controlled-release composition - Google Patents

A controlled-release composition

Info

Publication number
SE8602931D0
SE8602931D0 SE8602931A SE8602931A SE8602931D0 SE 8602931 D0 SE8602931 D0 SE 8602931D0 SE 8602931 A SE8602931 A SE 8602931A SE 8602931 A SE8602931 A SE 8602931A SE 8602931 D0 SE8602931 D0 SE 8602931D0
Authority
SE
Sweden
Prior art keywords
phase
active material
biologically active
controlled
monoglyceride
Prior art date
Application number
SE8602931A
Other languages
English (en)
Other versions
SE457693B (sv
SE8602931L (sv
Inventor
Sven Engstrom
Kare Larsson
Bjorn Lindman
Original Assignee
Sven Engstrom
Kare Larsson
Bjorn Lindman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Engstrom, Kare Larsson, Bjorn Lindman filed Critical Sven Engstrom
Priority to SE8602931A priority Critical patent/SE457693B/sv
Publication of SE8602931D0 publication Critical patent/SE8602931D0/sv
Priority to CA000538239A priority patent/CA1296631C/en
Priority to JP62504060A priority patent/JPH0759523B2/ja
Priority to AT87904411T priority patent/ATE74277T1/de
Priority to EP19870904411 priority patent/EP0314689B1/en
Priority to DE87904411T priority patent/DE3778024D1/de
Priority to PCT/SE1987/000279 priority patent/WO1988000059A1/en
Publication of SE8602931L publication Critical patent/SE8602931L/sv
Priority to NO880560A priority patent/NO175454C/no
Priority to DK105888A priority patent/DK105888D0/da
Priority to FI886055A priority patent/FI97687C/sv
Publication of SE457693B publication Critical patent/SE457693B/sv
Priority to US08/107,908 priority patent/US5371109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8602931A 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas SE457693B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
CA000538239A CA1296631C (en) 1986-07-01 1987-05-28 Controlled-release composition
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
EP19870904411 EP0314689B1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
AT87904411T ATE74277T1 (de) 1986-07-01 1987-06-12 Zubereitung eines in einer l2-phase geloesten oder dispergierten biologischen aktiven materials mit geregelter verabreichung.
JP62504060A JPH0759523B2 (ja) 1986-07-01 1987-06-12 調節放出組成物
DE87904411T DE3778024D1 (sv) 1986-07-01 1987-06-12
NO880560A NO175454C (no) 1986-07-01 1988-02-09 Fremgangsmåte for fremstilling av et preparat som har form av en L2-fase
DK105888A DK105888D0 (da) 1986-07-01 1988-02-29 Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel
FI886055A FI97687C (sv) 1986-07-01 1988-12-30 Komposition för kontrollerad utlösning av ett biologiskt aktivt material löst eller dispergerat i en L2-fas
US08/107,908 US5371109A (en) 1986-07-01 1993-08-18 Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Publications (3)

Publication Number Publication Date
SE8602931D0 true SE8602931D0 (sv) 1986-07-01
SE8602931L SE8602931L (sv) 1988-01-02
SE457693B SE457693B (sv) 1989-01-23

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Country Status (8)

Country Link
EP (1) EP0314689B1 (sv)
JP (1) JPH0759523B2 (sv)
CA (1) CA1296631C (sv)
DE (1) DE3778024D1 (sv)
DK (1) DK105888D0 (sv)
FI (1) FI97687C (sv)
SE (1) SE457693B (sv)
WO (1) WO1988000059A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
EP0429419B1 (en) * 1989-10-20 1996-02-14 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
WO1999012640A1 (en) * 1997-09-09 1999-03-18 Select Release, L.C. Coated particles, methods of making and using
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
DK105888A (da) 1988-02-29
EP0314689B1 (en) 1992-04-01
FI97687B (sv) 1996-10-31
DE3778024D1 (sv) 1992-05-07
SE457693B (sv) 1989-01-23
DK105888D0 (da) 1988-02-29
CA1296631C (en) 1992-03-03
FI97687C (sv) 1997-02-10
JPH0759523B2 (ja) 1995-06-28
JPH01503140A (ja) 1989-10-26
WO1988000059A1 (en) 1988-01-14
EP0314689A1 (en) 1989-05-10
FI886055A (sv) 1988-12-30
SE8602931L (sv) 1988-01-02

Similar Documents

Publication Publication Date Title
SE8602931D0 (sv) A controlled-release composition
Nicolaides et al. The skin surface lipids of man compared with those of eighteen species of animals
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
ATE33938T1 (de) Herstellungsverfahren von zusammensetzungen mit kontrolliertem verabreichen biologisch aktiver materialien.
JPS5777626A (en) Palatable composition containing oil or oily substance
FI964959A (sv) Lipidbaserad sammansättning innehållande diacylglycerol, fosfolipid, plas vätska och biologiskt aktivt material
BG93923A (bg) Метод за получаване на състав за контролирано освобождаване на активното вещество
DK312583A (da) Kortikoidholdigt praeparat til topisk applikation
SE8305316D0 (sv) Topiskt applicerbart preparat
DK287186A (da) Fremgangsmaade til fremstilling af fiskefoder
FI61123C (fi) Foerfarande foer framstaellning av en fettprodukt som laempar sig foer framstaellning av avkortningsmedel och emulgerade livsmedelspastor
Marchello et al. Bovine serum lipids. I. The influence of added animal fat to the ration
Ando et al. Antitumor activity of glyceryl ethers
FR2584925B1 (fr) Composition de corps gras d'origine vegetale pour usage cosmetique
JPS5517328A (en) Insulin-containing emulsion and its preparation
GB2150588A (en) Shampoo for promoting growth of hair
JPS54110210A (en) Preparation of oil for meat-roasting hot plate
JPS5759627A (en) Solubilization
ES487362A0 (es) Procedimiento para la preparacion de composiciones mixtas decetoperoxidos
Pookboonmee et al. Application of surfactant aqueous-based solution for oil and phorbol esters extraction from Jatropha curcas L. seed-kernel in one step
JPS5564755A (en) Shortening for "baumkuchen" (germany cake)
ES8404849A1 (es) Metodo para la preparacion de composiciones farmaceuticas conteniendo sulfadiazina de plata como sustancia activa.
JPS55165751A (en) Creamy composition
JPS5550867A (en) Improvement in color of fried food
JPS53145927A (en) Emulsion for hair treatment

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602931-1

Effective date: 19940210

Format of ref document f/p: F